SCM
CERE

Silverarc Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Silverarc Capital Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,000
Closed -$1.66K – 105
2021
Q2 		$1.66K Buy
+15,000
New +$1.66K 0.74% 48